Search

Your search keyword '"Curigliano, A."' showing total 335 results

Search Constraints

Start Over You searched for: Author "Curigliano, A." Remove constraint Author: "Curigliano, A." Publisher elsevier ltd Remove constraint Publisher: elsevier ltd
335 results on '"Curigliano, A."'

Search Results

1. Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAFV600E wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial

2. Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers

5. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer

8. Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials

9. 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

12. Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review

13. Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study

15. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer

21. Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network—Breast dataset (SCAN-B)

22. Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00

24. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer

25. International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations

26. EUSOMA quality indicators for non-metastatic breast cancer: An update

27. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

32. The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development

35. Treatment and outcomes in breast cancer patients: A cross section study from the EUSOMA breast centre network

37. Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response

39. Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study

40. Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread

41. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

42. ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC)

47. Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis

50. Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments

Catalog

Books, media, physical & digital resources